Company news
Recce Pharmaceuticals Ltd. news in 2016
Recce Pharmaceuticals Ltd.'s news releases, calls and decks from 2016, newest first.
Encouraging anti-viral activity for lead compound RECCE 327
December 20, 2016
Pre-clinical toxicology and efficacy testing
November 2, 2016
Dose Ranging in Mice - Repeated Success
August 15, 2016
Successful Test Results for Genetic Toxicity
July 20, 2016
Anti-viral Activity
July 13, 2016
Update on Testing Schedules
June 20, 2016
Encouraging Results from Safety Test
May 25, 2016
Recce - The Way Forward
May 2, 2016
Progress Update
April 10, 2016
International Trade Mark Registrations
April 5, 2016
Anti-cancer Activities
March 13, 2016
Appendix 4D and Half Year Financial Statements
February 26, 2016
Efficacy without Toxicity
February 11, 2016
RECCE Antibiotic kills TB and Gonorrhoea
February 10, 2016
Patent Granted in China
February 10, 2016
Admission to Official List
February 10, 2016
Additional Patent Developments
February 10, 2016
Decks in 2016
- Investor Presentation (January 2016)
Investor deck · 28 slides · Jan 18, 2016